The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches

AP Alarcón-Zendejas, A Scavuzzo… - Prostate cancer and …, 2022 - nature.com
Background Risk stratification or progression in prostate cancer is performed with the
support of clinical-pathological data such as the sum of the Gleason score and serum levels …

Harnessing artificial intelligence for prostate cancer management

L Zhu, J Pan, W Mou, L Deng, Y Zhu, Y Wang… - Cell Reports …, 2024 - cell.com
Prostate cancer (PCa) is a common malignancy in males. The pathology review of PCa is
crucial for clinical decision-making, but traditional pathology review is labor intensive and …

Automatic diagnosis and grading of prostate cancer with weakly supervised learning on whole slide images

J Xiang, X Wang, X Wang, J Zhang, S Yang… - Computers in Biology …, 2023 - Elsevier
Background: The workflow of prostate cancer diagnosis and grading is cumbersome and the
results suffer from substantial inter-observer variability. Recent trials have shown potential in …

Artificial intelligence-enabled prostate cancer diagnosis and prognosis: current state and future implications

S Satturwar, AV Parwani - Advances in Anatomic Pathology, 2024 - journals.lww.com
In this modern era of digital pathology, artificial intelligence (AI)-based diagnostics for
prostate cancer has become a hot topic. Multiple retrospective studies have demonstrated …

An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading

Y Tolkach, V Ovtcharov, A Pryalukhin, ML Eich… - NPJ precision …, 2023 - nature.com
Pathologic examination of prostate biopsies is time consuming due to the large number of
slides per case. In this retrospective study, we validate a deep learning-based classifier for …

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial

T Sumiyoshi, X Wang, EW Warner… - JNCI: Journal of the …, 2024 - academic.oup.com
Abstract Background The phase 3 CALGB 90203 (Alliance) trial evaluated neoadjuvant
chemohormonal therapy for high-risk localized prostate cancer before radical prostatectomy …

Applications of artificial intelligence in prostate cancer histopathology

D Busby, R Grauer, K Pandav, A Khosla, P Jain… - … Oncology: Seminars and …, 2023 - Elsevier
The diagnosis of prostate cancer (PCa) depends on the evaluation of core needle biopsies
by trained pathologists. Artificial intelligence (AI) derived models have been created to …

[HTML][HTML] Advancing precision medicine: algebraic topology and differential geometry in radiology and computational pathology

RM Levenson, Y Singh, B Rieck, QA Hathaway… - Laboratory …, 2024 - Elsevier
Precision medicine aims to provide personalized care based on individual patient
characteristics, rather than guideline-directed therapies for groups of diseases or patient …

[HTML][HTML] Artificial intelligence-based prediction for cancer-related outcomes in Africa: status and potential refinements

J Adeoye, A Akinshipo, P Thomson… - Journal of Global …, 2022 - ncbi.nlm.nih.gov
2021 Deep learning Detection of HSIL and LSIL in cervical cancer Phase I-III Internal
0.97[18] 2018 Machine learning Breast cancer staging Phase I, II, IV NIL 0.84[19] 2021 …

Don't fear the artificial intelligence: a systematic review of machine learning for prostate cancer detection in pathology

A Frewing, AB Gibson, R Robertson… - … of Pathology & …, 2024 - meridian.allenpress.com
Context Automated prostate cancer detection using machine learning technology has led to
speculation that pathologists will soon be replaced by algorithms. This review covers the …